Researchers are looking for valuable insights to further combat COVID-19 after the National Institute of Virology in Pune has successfully isolated the infection.
The deadly coronavirus, which originated from Wuhan in China, has spread to many countries wrecking havoc globally. In India, more than 1,000 cases have been reported and nearly 30 deaths.
Raman R Gangakhedkar, Head of Epidemiology and Communicable diseases at ICMR, had earlier said the National Institute of Virology (NIV) in Pune has been successful in isolating the virus, which is a prime requisite for doing any kind of research related to viruses.
"There are two ways of going for vaccine preparation. One is either you look at the sequences of the gene which may then lead to development of antibodies or you actually have the strain and then you try to develop a vaccine which is always an easier option," he said.
Researchers at NIV are now hoping to get some valuable insights to further combat COVID-19.
"In order to look at newer drugs that might come, we are soon likely to participate in the WHO solidarity trial for COVID-19,"Gangakhedkar said.
"Earlier, we did not do it because our numbers were so small and our contribution would have looked minuscule," he said.
He said the initial priority of the Indian Council of Medical Research (ICMR) in developing drugs is more towards re-purposed molecules than new molecules because new molecule research tends to take longer time.
"And we don't have so much time when we are facing this infection," he said.
Health experts while appreciating the attempts in laboratory to seek a solution to tackle this global menace urged authorities to go for large-scale testing
Neha Gupta, Consultant, Infectious Disease Specialist Fortis Memorial Research Institute here said, "What we are following in the hospitals is that if a patient presents with flu-like symptoms such as fever, headache, sour throat and chest X-ray showing infiltrates, then the patient is a suspected COVID-19 cases."
The first images of coronavirus have been captured by scientists in Pune using transmission electron microscope imaging from throat swab of the first positive case in the country, a medical student from the Wuhan University and a native of Kerala,
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
